W J Cromartie
University of North Carolina at Chapel Hill
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by W J Cromartie.
Gastroenterology | 1985
R. Balfour Sartor; W J Cromartie; Don W. Powell; John H. Schwab
This study was designed to determine if poorly biodegradable bacterial cell wall components can produce chronic intestinal inflammation. A sterile aqueous suspension of sonically disrupted group A or group D streptococcal cell wall fragments was injected intramurally into the small intestine and cecum of 100 rats. Gross findings in rats killed at intervals of 1 day to 6 mo included intestinal thickening, adhesions, and mesenteric contraction. Acute histologic inflammation subsided by 2 wk, but chronic granulomatous inflammation persisted for 6 mo in the rats injected with group A streptococcal cell wall fragments and 3 mo in the rats injected with group D streptococcal cell wall fragments. Ninety-six control rats identically injected with human serum albumin or phosphate-buffered saline demonstrated mild acute inflammation that resolved, with only 1 rat having chronic intestinal inflammation. Granulomas in the intestine, mesentery, and mesenteric lymph nodes developed in 46% of the rats injected with group A fragments and 45% of the rats injected with group D streptococcal cell wall fragments, compared with 20% of the controls injected with albumin and 4% of the controls injected with phosphate-buffered saline. Group A streptococcal antigen was detected by immunofluorescence at the site of inflammation for 4 mo, and possible reactivation of acute inflammation was seen up to 6 mo after injection. We conclude that bacterial cell wall fragments are capable of producing chronic granulomatous inflammation in the intestinal wall if present in appropriate particle size and concentration. We speculate that cell walls from the enteric microflora may leak across a permeable mucosa in chronic inflammatory bowel disease to initiate and sustain local and systemic inflammation.
Archive | 1986
Stephen A. Stimpson; Ronald E. Esser; W J Cromartie; John H. Schwab
Lipopolysaccharide (LPS) and covalent complexes of peptidoglycan and polysaccharide (PG-PS) are the major toxic components of bacterial cell walls. The lipid A and peptidoglycan moieties are responsible for much of the biological activity of LPS and PG-PS, respectively. Both are ubiquitous in the environment and have many biological properties in common, including polyclonal activation of lymphoid cells, complement activation, mitogenicity, macrophage activation, and adjuvanticity (3,8,10,11). In spite of these similarities, the interaction or complementation of the phlogistic properties of these toxic polymers in inflammation has received little attention.
Journal of Experimental Medicine | 1977
W J Cromartie; J G Craddock; Joseph H. Schwab; S K Anderle; Cao Yang
Arthritis & Rheumatism | 1979
Richard L. Clark; John T. Cuttino; Sonia K. Anderle; W J Cromartie; John H. Schwab
Infection and Immunity | 1986
S A Stimpson; Roger R. Brown; Sonia K. Anderle; D G Klapper; R L Clark; W J Cromartie; John H. Schwab
Infection and Immunity | 1982
R Eisenberg; Alvin Fox; J J Greenblatt; Sonia K. Anderle; W J Cromartie; John H. Schwab
Arthritis & Rheumatism | 1985
Ronald E. Esser; Stephen A. Stimpson; W J Cromartie; John H. Schwab
Journal of Experimental Medicine | 1987
Stephen A. Stimpson; Ronald E. Esser; P B Carter; R B Sartor; W J Cromartie; John H. Schwab
Journal of Experimental Medicine | 1959
John H. Schwab; W J Cromartie; Bob S. Roberson
Infection and Immunity | 1986
S A Stimpson; R E Esser; W J Cromartie; John H. Schwab